ICU Medical | ICUI - Ebitda



金融业
股票价格
USD
资产
USD 3.97B
现金及等价物
USD 288.33M
销售成本
USD 316.63M
流动资产
USD 1.21B
流动负债
USD 498.36M
债务
USD 1.23B
EBIT
USD 60.43M
EBITDA
USD 110.03M
员工
15K
EPS每股收益
USD 2.37
股本和储备
USD 2.15B
销售毛利
USD 235.05M
债务利息支出
USD 18.53M
利息收入
USD 2.04M
贷款资金
USD 1.21B
市值
USD 3.77B
净收入
USD 19.09M
营业费用
USD 491.25M
营业利润
USD 60.43M
普通股股本
USD 24.99M
PE价格收益
30.44
税前利润
USD -3.98M
销售收入
USD 551.68M
销售和管理费用
USD 151.92M
股票
USD 607.42M
贸易债权人
USD 149.17M
应收帐款人
USD 183.53M


Ebitda 更改 日
Align Technology USD 229.14M 31.74M 2026-03
AngioDynamics USD 5.94M 3.78M 2025-09
Baxter International USD 309M 756M 2026-03
Becton, Dickinson and Co. USD 1.71B 1B 2026-06
Cooper Companies USD 67.9M 255.5M 2026-03
Edwards Lifesciences USD 555.6M 485.5M 2026-03
Haemonetics USD 96.17M 91.87M 2026-06
ICU Medical USD 110.03M 11.35M 2026-06
Insulet USD 199.8M 18.1M 2026-06
Merit Medical Systems USD 104.39M 10.97M 2026-06
Neogen USD 45.4M 2.8M 2026-03
OraSure Technologies USD -17.7M 4.06M 2025-12
Quidel USD 129.3M 20.6M 2026-06
STAAR Surgical USD 20M 387K 2026-06
Teleflex USD 75.63M 171.44M 2026-03
West Pharmaceutical Services USD 243.6M 17.4M 2026-06